Arbor Pharms Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ARBOR PHARMS LLC, and when can generic versions of ARBOR PHARMS LLC drugs launch?
ARBOR PHARMS LLC has seventeen approved drugs.
There are seven US patents protecting ARBOR PHARMS LLC drugs.
There are thirty-seven patent family members on ARBOR PHARMS LLC drugs in thirty-one countries and thirteen supplementary protection certificates in eleven countries.
Summary for Arbor Pharms Llc
International Patents: | 37 |
US Patents: | 7 |
Tradenames: | 18 |
Ingredients: | 9 |
NDAs: | 17 |
Drugs and US Patents for Arbor Pharms Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Arbor Pharms Llc | EVEKEO ODT | amphetamine sulfate | TABLET, ORALLY DISINTEGRATING;ORAL | 209905-002 | Jan 30, 2019 | RX | Yes | No | 10,130,580 | See Plans and Pricing | Y | See Plans and Pricing | |||
Arbor Pharms Llc | EVEKEO ODT | amphetamine sulfate | TABLET, ORALLY DISINTEGRATING;ORAL | 209905-001 | Jan 30, 2019 | RX | Yes | No | 10,441,554 | See Plans and Pricing | Y | See Plans and Pricing | |||
Arbor Pharms Llc | ERYTHROMYCIN ETHYLSUCCINATE | erythromycin ethylsuccinate | TABLET;ORAL | 061904-001 | Approved Prior to Jan 1, 1982 | BX | RX | No | Yes | See Plans and Pricing | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Arbor Pharms Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Arbor Pharms Llc | GLIADEL | carmustine | IMPLANT;INTRACRANIAL | 020637-001 | Sep 23, 1996 | 5,179,189 | See Plans and Pricing |
Arbor Pharms Llc | GLIADEL | carmustine | IMPLANT;INTRACRANIAL | 020637-001 | Sep 23, 1996 | 4,757,128 | See Plans and Pricing |
Arbor Pharms Llc | SKLICE | ivermectin | LOTION;TOPICAL | 202736-001 | Feb 7, 2012 | 6,103,248 | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ARBOR PHARMS LLC drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Lotion | 0.5% | ➤ Subscribe | 2017-09-01 |
International Patents for Arbor Pharms Llc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Hungary | E040391 | See Plans and Pricing |
Croatia | P20161785 | See Plans and Pricing |
Ukraine | 99830 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Arbor Pharms Llc Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1620113 | C300756 | Netherlands | See Plans and Pricing | PRODUCT NAME: IVERMECTINE VOOR TOEPASSING IN; NAT. REGISTRATION NO/DATE: RVG 115310 20150504; FIRST REGISTRATION: MA117/01101 20150402 |
0260415 | C990036 | Netherlands | See Plans and Pricing | PRODUCT NAME: CARMUSTINE; NAT. REGISTRATION NO/DATE: RVG 24056 19990809; FIRST REGISTRATION: FR 561 907-5 19981210 |
1620113 | CA 2015 00045 | Denmark | See Plans and Pricing | PRODUCT NAME: IVERMECTIN, 22, 23-DIHYDROAVERMECTINB1A + 22,23-DIHRODROAVERMECTIN B1B FOR USE IN THE TREATMNET OF RESACEA; NAT. REG. NO/DATE: 54123 20150422; FIRST REG. NO/DATE: MT MA 117/01101 20150402 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.